Adverse Events Module

Adverse Events Module

For researchers submitting trial data to ClinicalTrials.gov, the Adverse Events module is one of four mandatory results sections. It requires reporting in three primary categories: All-Cause Mortality: A table tracking all deaths that occurred during the study, regardless of cause. Serious Adverse Events (SAEs): A tabular summary of events resulting in death, life-threatening conditions, hospitalization, or significant disability. Other Adverse Events: A table for non-serious events that exceed a specific frequency threshold, such as 5% within any study arm.

Adverse Events Module path is as follows:

Study -> Results Section -> Adverse Events Module -> Event Groups

Study -> Results Section -> Adverse Events Module -> Serious Events

Study -> Results Section -> Adverse Events Module -> Other Events

Adverse Events Module


Ignite Creation Date: 2025-12-24 @ 1:06 PM
Ignite Modification Date: 2025-12-25 @ 12:21 PM
NCT ID: NCT01205061
Description: The safety population included all participants who received at least one injection.
Frequency Threshold: 3
Time Frame: From start of study drug administration up to 62 weeks
Study: NCT01205061
Study Brief: Emervel® Deep Lidocaine vs. Juvederm® Ultra Plus in Treatment of Moderate to Severe Facial Wrinkles and Folds
Event Groups(If Any):

Event Groups

Title Description Deaths # Affected Deaths # At Risk Serious # Affected Serious # At Risk Other # Affected Other # At Risk View
Emervel Deep Lidocaine NLFs were injected with Emervel Deep Lidocaine (20 mg/mL with 0.3% lidocaine). 0 None 7 162 16 162 View
Juvederm Ultra Plus NLFs were injected with Juvéderm Ultra Plus (24 mg/mL). 0 None 7 162 16 162 View
Serious Events(If Any):

Serious Events

Term Type Organ System Vocab View
Lung cancer metastatic NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (13.0) View
Uterine Leiomyoma NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (13.0) View
Diarrhoea infections NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Small intestinal obstruction NON_SYSTEMATIC_ASSESSMENT Gastrointestinal disorders MedDRA (13.0) View
Ovarian Cyst NON_SYSTEMATIC_ASSESSMENT Reproductive system and breast disorders MedDRA (13.0) View
Colon cancer NON_SYSTEMATIC_ASSESSMENT Neoplasms benign, malignant and unspecified (incl cysts and polyps) MedDRA (13.0) View
Herpes Zoster NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Lumbar Spinal stenosis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Other Events(If Any):

Other Events

Term Type Organ System Vocab View
Upper respiratory tract infection NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Sinusitis NON_SYSTEMATIC_ASSESSMENT Infections and infestations MedDRA (13.0) View
Migraine NON_SYSTEMATIC_ASSESSMENT Nervous system disorders MedDRA (13.0) View